• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 4th June 2010

News Release: Report on Patient Choice in the UK

A report published today by The King’s Fund shows that having a choice of hospitals is valued by the majority of patients. However, it is not yet operating as intended and has not so far acted as a lever to…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

A report published today by The King’s Fund shows that having a choice of hospitals is valued by the majority of patients. However, it is not yet operating as intended and has not so far acted as a lever to improve quality and increase competition.

Thursday, 3 June 2010

Support for patient choice but it is not yet driving quality improvements, says new report

A report published today by The King’s Fund shows that having a choice of hospitals is valued by the majority of patients. However, it is not yet operating as intended and has not so far acted as a lever to improve quality and increase competition.

Since April 2008, patients in England have been able to choose treatment from any hospital in a national directory. The new report Patient Choice: How patients choose and how providers respond – published jointly with the Picker Institute, RAND Europe and the Office of Health Economics – assesses how patient choice is operating based on research with patients, GPs and hospital providers. The research found that:

  • While 75 per cent of patients want to choose where they are treated, only around half recall being offered a choice by their GPs.
  • Only 8 per cent of those offered a choice recalled being offered the option of choosing a private provider.[i]
  • Most patients remain loyal to their local hospital (69% choose to be treated there).
  • Having a bad experience of their local hospital is a major reason why patients choose to access care from an alternative provider.
  • Few patients are making use of performance data to inform their choices – just 4 per cent of patients consulted the NHS Choices website – with most preferring to rely on their own experience or the advice of their GP.
  • GPs said they were offering choice routinely but this was rarely a meaningful discussion of the options available.

While GPs broadly supported the idea of patient choice, many who took part in the research underestimated its importance to patients, distrusted comparative performance data and felt unable to advise patients on referrals outside their local area. They also strongly criticised Choose and Book, the electronic system for booking appointments for treatment, which has been weighed down by technical problems since its inception.

The report shows that choice is not yet acting as a sufficiently strong lever to improve quality or increase competition, as the policy intended. The main focus of competitive activity among providers is securing GP referrals rather than directly competing for patients, and this really only occurs at the boundaries of their catchment areas. Interviews with providers revealed that in many cases they are choosing to cooperate rather than compete with each other.

The research also debunks commonly held assumptions that only certain groups are interested in patient choice. Patients living in non-urban areas were more likely to be offered a choice and more likely to choose to travel beyond their local provider than those in urban areas. Older patients, those from mixed or non-white backgrounds and those with no qualifications were more likely to think having a choice is important.

However, while there were no apparent inequities among those who were offered a choice, older, more educated patients were more likely to choose a non-local provider. This suggests a potential risk that, where local providers are providing poor quality services, some patients may be ‘left behind’ while others exercise their right to choose to be treated elsewhere.

Anna Dixon, Director of Policy at The King’s Fund and the report’s lead author, said:

‘Patients clearly value choice, even if in most cases they prefer to stay with their local provider. Choice does appear to be having an indirect effect on quality by motivating providers to maintain their reputation in order to avoid losing patients. But the reluctance to implement choice among GPs and little use of performance data by patients suggests there are still a number of significant challenges that need to be overcome if the policy is to be implemented as policy makers originally envisaged.

‘While it is still early days, we are some way from realising the vision of choice acting as a lever to improve quality, with informed patients choosing the highest performing providers in a competitive market.’

ENDS


[i] Since April 2008, all patients referred by their GP for a non-urgent hospital appointment have had the choice to be treated at eligible private sector providers as well as NHS hospitals.  

  • EQ-5D and PROMs
  • News Releases

Related News

  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
  • News
  • October 2021

We have launched OHE Bulletin, a new monthly newsletter

Read more
Danzon_Patricia_1305 (1)
  • News
  • June 2020

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

Read more
  • News
  • October 2019

Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!